Individuals Stopping Anti-Obesity Medications Gain Back Pounds Far More Rapidly Than Those on Conventional Diets

New research indicates that patients who stop using blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise programs.

Published data in a prominent medical journal shows that while obese individuals often shed a large proportion of their body weight while on the medication, the mass returns at an average rate of 0.8 kg per month after stopping.

"Users using these drugs must be cognizant of the risk of quick weight regain when the medication concludes," warns expert Dr. Susan Jebb.

Such speed of recovery means a return to original weight in about 18 months.

Analyzing Therapies

The analysis, which reviewed dozens of trials involving thousands of patients, contrasted the effects of GLP-1 agonists with older methods.

The team emphasize that people who shed pounds through diet and exercise usually have a less rapid weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Quick Rebound

Doctors believe the mode of action of the jabs is key to understanding the accelerated rebound.

These medications copy a natural hormone called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating far more likely."

A Chronic Disease?

The NHS suggest the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

A number of clinicians say that, considering the likelihood of weight regain, the treatment should be considered long-term.

This perspective is echoed by pharmaceutical companies, who say that the results "highlight the long-term character of excess weight," similar to managing diseases like hypertension.

User Experiences

People who have stopped the jabs describe a powerful return of cravings.

"It felt as if a switch activating and you're instantly ravenous," described an individual.

This difficulty is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.

Widespread Interest

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.

• Adoption is more common among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the medications through private healthcare rather than public health services.

In conclusion, experts emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle management.